Microalbuminuria is associated with impaired glomerular permselectivity in lymphoma patients

References

• Viberti G. C., Wiseman M. J. The kidney in diabetes: significance of the early abnormalities. Clin Endocrinol Metab 1986; 15: 783–806
   PubMedGoogle Scholar
• Pedersen L. M., Milman N. Microalbuminuria in patients with lung cancer. Eur J Cancer 1998; 34: 76–80
   PubMed Web of Science ®Google Scholar
• Pedersen L. M., Sørensen P. G. Clinical significance of urinary albumin excretion in patients with non‐Hodgkin's lymphoma. Br J Haematol 1999; 107: 889–91
   PubMed Web of Science ®Google Scholar
• Pedersen L. M., Sørensen P. G. Increased urinary albumin excretion rate in breast cancer patients. Acta Oncol 2000; 39: 145–9
   PubMedGoogle Scholar
• Pedersen L. M., Sørensen P. G. Mediators of inflammation correlate with microalbuminuria in patients with non‐Hodgkin's lymphoma. Br J Haematol 2003; 121: 275–9
   PubMedGoogle Scholar
• Pedersen L. M., Nordin H., Svensson B., Bliddal H. Microalbuminuria in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 189–92
   PubMed Web of Science ®Google Scholar
• Mahmud N., Stinson J., O'Connell M. A., Mantle T. J., Keeling P. W., Feely J., et al. Microalbuminuria in inflammatory bowel disease. Gut 1994; 35: 1599–604
   PubMed Web of Science ®Google Scholar
• Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001; 357: 539–45
   PubMed Web of Science ®Google Scholar
• Preti H. A., Cabanillas F., Talpaz M., Tucker S. L., Seymour J. F., Kurzrock R. Prognostic value of serum interleukin‐6 in diffuse large cell lymphoma. Ann Intern Med 1997; 127: 186–94
   PubMed Web of Science ®Google Scholar
• Lejune F. J., Ruegg C., Lienard D. Clinical applications of TNF‐α in cancer. Curr Opin Immunol 1998; 10: 573–80
   PubMedGoogle Scholar
• Warzocha K., Salles G., Bienvenu J., Bastion Y., Dumontet C., Renard N., et al. Tumor necrosis factor ligand‐receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol 1997; 15: 499–508
   PubMed Web of Science ®Google Scholar
• Fayad L., Cabanillas F., Talpaz M., McLaughlin P., Kurzrock R. High serum interleukin‐6 levels correlate with a shorter failure‐free survival in indolent lymphoma. Leuk Lymphoma 1998; 30: 563–71
   PubMed Web of Science ®Google Scholar
• Pedersen L. M., Sørensen P. G. Urinary albumin excretion is a predictor of response to treatment and disease progression in low‐grade non‐Hodgkin's lymphoma. Leuk Lymphoma 2004; 45: 547–51
   PubMedGoogle Scholar
• Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiani M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860–1
   PubMed Web of Science ®Google Scholar
• The International Non‐Hodgkin's Lymphoma Prognostic Factor Project (1993). A predictive model for aggressive non‐Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–94
   PubMed Web of Science ®Google Scholar
• Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantification of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235–54
   PubMedGoogle Scholar
• Wu J. T., Clayton F., Myers S., Knight J. A simple radial immunodiffusion method for assay of β2‐microglobulin in serum. Clin Chem 1986; 32: 2070–3
   PubMedGoogle Scholar
• Deckert T., Feldt‐Rasmussen B., Djurup R., Deckert M. Glomerular size and charge selectivity in insulin‐dependent diabetes mellitus. Kidney Int 1988; 33: 100–6
   PubMed Web of Science ®Google Scholar
• Gosling P. Microalbuminuria: a sensitive indicator of non‐renal disease?. Ann Clin Biochem 1995; 32: 439–41
   PubMedGoogle Scholar
• Deen W. M., Lazzara M. J., Myers B. D. Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 2001; 281: F579–96
   PubMed Web of Science ®Google Scholar
• Brenner B. M., Hostetter T. H., Humes H. D. Molecular basis of proteinuria of glomerular origin. N Engl J Med 1978; 298: 826–33
   PubMed Web of Science ®Google Scholar
• Russo L. M., Bakris G. L., Comper W. D. Renal handling of albumin: a critical review of basic concepts and perspective. Am J Kidney Dis 2002; 39: 899–919
   PubMed Web of Science ®Google Scholar
• Maddox D. A., Deen W. M., Brenner B. M. Glomerular filtration. Handbook of physiology. Renal physiology. Am Physiol Soc, Bethesda 1992; pp 545–638, sect. 8, vol. I, ch. 13
   Google Scholar
• Ison M., Sorensson J., Haraldsson B. A gel‐membrane model of glomerular charge and size selectivity in series. Am J Physiol Renal Physiol 2001; 280: F396–F405
   Google Scholar
• Osicka T. M., Pratt L. M., Comper W. D. Glomerular capillary wall permeability to albumin and horseradish peroxidase. Nephrology 1996; 2: 199–212
   Google Scholar
• Schaeffer R. C., Jr, Gratrix M. L., Mucha D. R., Carbajal J. M. The rat glomerular filtration barrier does not show negative charge selectivity. Microcirculation 2002; 9: 329–42
   PubMedGoogle Scholar
• Deen W. M., Lazzara M. J., Myers B. D. Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 2001; 281: F579–F96
   PubMed Web of Science ®Google Scholar
• Wolgast M., Kallskog O., Wahlstrom H. Characteristics of the glomerular capillary membrane of the rat kidney as a hydrated gel. II. On the validity of the model. Acta Physiol Scand 1996; 158: 225–32
   PubMedGoogle Scholar
• Comper W. D., Glasgow E. F. Charge selectivity in kidney ultrafiltration. Kidney Int 1995; 47: 1242–51
   PubMedGoogle Scholar
• Hemmelder M. H., de Zeeuw D., de Jong P. E. Measurement of glomerular charge selectivity in non‐diabetic renal disease. Nephrol Dial Transplant 1997; 12(Suppl 2)57–62
   PubMedGoogle Scholar
• Bolton G. R., Deen W. M., Daniels B. S. Assessment of the charge selectivity of glomerular basement membrane using Ficoll sulfate. Am J Physiol Renal Physiol 1998; 274: F889–F96
   PubMed Web of Science ®Google Scholar
• Bohrer M. P., Patterson G. D., Carroll P. J. Hindered diffusion of dextran and Ficoll in microporous membranes. Macromolecules 1984; 17: 1170–3
   Web of Science ®Google Scholar
• Hemmelder M. H., De Jong P. E., De Zeeuw D. A comparison of analytic procedures for measurement of fractional dextran clearances. J Lab Clin Med 1998; 132: 390–403
   PubMedGoogle Scholar
• Guasch A., Deen W. M., Myers B. D. Charge‐selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J Clin Invest 1993; 92: 2274–82
   PubMed Web of Science ®Google Scholar
• Jensen J. S., Borch‐Johnsen K., Deckert T., Deckert M., Jensen G., Feldt‐Rasmussen B. Reduced glomerular size‐ and charge‐selectivity in clinically healthy individuals with microalbuminuria. Eur J Clin Invest 1995; 25: 608–14
   PubMed Web of Science ®Google Scholar
• Sagratella E., Doldo P., Luzza F., Di Mario U., Pallone F. Altered IgG4 renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity. Nephrol Dial Transplant 2000; 15: 498–501
   PubMedGoogle Scholar
• Mahmud N., O'Connell M. A., Stinson J., Goggins M. G., Weir D. G., Kelleher D. Tumour necrosis factor‐alpha and microalbuminuria in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 215–9
   PubMed Web of Science ®Google Scholar
• Pedrinelli R., Dell'Omo G., Penno G., Mariani M. Non‐diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease. Vasc Med 2001; 6: 257–64
   PubMedGoogle Scholar
• Stehouwer C. D., Gall M. A., Twish J. W., Knudsen E., Emeis J. J., Parving H. H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low‐grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002; 51: 1157–65
   PubMed Web of Science ®Google Scholar